Authors
Amin Roshdy Soliman, Amr Abdel Hady El Meligi, Amira Nashat Youssef Aziz
Published in
Diabetes research and clinical practice. Pages 113661. Nov 12, 2026. Epub Nov 12, 2026.
Abstract
Body mass index (BMI) may not adequately identify excess adiposity and cardiometabolic risk, particularly in young adults. This narrative non-systematic review evaluates the complementary roles of body fat percentage (BFP), the Finnish Diabetes Risk Score (FINDRISC), and the Clínica Universidad de Navarra Body Adiposity Estimator (CUN-BAE) in cardiometabolic risk assessment. Clinical practice guidelines, peer-reviewed studies, and the illustrative conference abstract by Mezzano et al. (2026 American Diabetes Association Scientific Sessions) were reviewed, focusing on normal-weight obesity, the utility of BFP and CUN-BAE, BMI limitations, and FINDRISC for assessing behavioral and familial diabetes risk. In the Mezzano et al. illustrative cohort of 152 medical students, BMI and BFP classified 7% and 22% as high risk, respectively, while 30% and 29% were classified as intermediate risk. Overall, 41% had at least one intermediate- or high-risk trait using combined BMI, CUN-BAE-derived BFP, and FINDRISC assessment. These findings are hypothesis-generating and limited by small sample size and cross-sectional design. BMI alone may inadequately characterize cardiometabolic risk. Combining CUN-BAE-estimated BFP with FINDRISC may improve detection of risk factors missed by BMI and offers a potentially feasible, low-cost approach for primary-care screening; however, prospective validation is required before clinical implementation.
PMID:
43020280
Bibliographic data and abstract were imported from PubMed on 13 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 10
- Comments 0